Drug Injury Lawyer Blog

Recent Posts from Drug Injury Lawyer Blog


  • New Safety Warnings About Diabetes Drug and Kidney Functions

    Recently, the safety warnings were strengthened for the diabetes drug Byetta relating to the risks of pancreatitis and the medicine’s use by patients with severe kidney disease. Specifically, the US Food and Drug Administration ("FDA")…

  • Video and Audio Cables: Are Consumers Paying More than Necessary?

    Consumers have paid upwards of $100 for cables whose performance is equal to a standard $10 six-foot HDMI cable. Many electronic stores and manufacturers have made claims that these “premium” cables outperform standard cables. However,…

  • Even More Dangers of Taking SSRIs When Pregnant Revealed

    According to a recently released Danish study, pregnant women taking an SSRI were twice as likely to have pre-term delivery as other women, and their babies were also more likely to be admitted to an…

  • Forced to Rent a Cable Box?

    Have you looked at your cable bill and found that you are paying $5, $6, and even $10 a month to rent a cable box from your service provider? Ever wonder why you cannot simply…

  • Another Medtronic Recall For Infusion Pumps

    In August 2009, Medtronic began informing physicians for the first time that, contrary to the labeling, its Sutureless Connector (SC) intrathecal catheters were incompatible with IsoMed Infusion Pump Model 8472, a drug delivery system for…

  • Unnecessary Replacement of Ink/Toner Cartridges Costing Consumers $$

    Any printer or all-in one (print-copy-fax) machine purchased within the last few years comes with its own software to install on your computer. This software includes updates regarding the amount of ink or toner remaining…

  • Credit Solutions Unable to Explain Failures

    As we reported here in May, the NY Attorney General filed suit against two debt consolidation firms in New York alleging fraudulent and deceptive business practices. Namely, the companies reportedly charge exorbitant consolidation fees while…

  • Risks of Heart Attack and Stroke with Asthma Drug Xolair

    On July 16, 2009, the FDA announced that it has begun a safety review of Genentech's asthma drug Xolair (omalizumab) after reports of an increased risk of heart attack, abnormal heart rhythm, heart failure, and…

  • SSRIs and the Suicidality Risk: Class Numbers Belie a Deeper Story

    On August 11, 2009, the British Medical Journal published an article detailing the results of a study aimed at measuring the association between modern antidepressants (Prozac, Paxil, Zoloft, Celexa, Lexapro, etc.) and increased suicidal thinking…

  • FDA Warns of Cancer Risks with TNF Blockers

    On August 4, 2009, the Food and Drug Administration stated that it had completed its analysis of tumor necrosis factor (TNF) blockers and has concluded that there is an increased risk of lymphoma and other…